Edition:
United Kingdom

Catalyst Pharmaceuticals Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

3.55USD
8:59pm GMT
Change (% chg)

$-0.07 (-1.93%)
Prev Close
$3.62
Open
$3.62
Day's High
$3.67
Day's Low
$3.51
Volume
144,681
Avg. Vol
227,794
52-wk High
$4.51
52-wk Low
$1.03

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.049
Jun '17 0.00 -0.046
Mar '17 0.00 -0.060
FY 2016 Dec '16 0.00 -0.050
Sep '16 0.00 -0.048
Jun '16 0.00 -0.055
Mar '16 0.00 -0.065
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 4 7.17 17.77 0.00 11.47
Earnings (per share)
Quarter Ending Mar-18 2 -0.07 -0.05 -0.09 --
Quarter Ending Jun-18 2 -0.07 -0.05 -0.09 --
Year Ending Dec-18 4 -0.28 -0.13 -0.45 -0.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.70 32.91
P/E High - Last 5 Yrs. -- 302.09 46.01
P/E Low - Last 5 Yrs. -- 94.18 24.39
Beta 1.63 0.88 0.89
Price to Sales (TTM) -- 94.43 5.45
Price to Book (MRQ) 6.89 13.36 5.40
Price to Tangible Book (MRQ) 6.89 13.64 6.91
Price to Cash Flow (TTM) -- 72.87 23.44
% Owned Institutions 41.23 11.52 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.72 5.21
Payout Ratio(TTM) -- 16.22 43.69

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 401.22 9.10
Sales (TTM) vs TTM 1 Yr. Ago -- 71.05 5.46
Sales - 5 Yr. Growth Rate -- 33.10 10.29
EPS (MRQ) vs Qtr. 1 Yr. Ago 16.13 29.49 19.71
EPS (TTM) vs TTM 1 Yr. Ago 16.48 -- --
EPS - 5 Yr. Growth Rate -- 40.21 10.75
Capital Spending - 5 Yr. Growth Rate 92.65 40.33 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.18
Current Ratio (MRQ) 19.43 5.23 2.98
LT Debt to Equity (MRQ) 0.00 21.05 12.13
Total Debt to Equity (MRQ) 0.00 22.61 16.42
Interest Coverage (TTM) -- -102.06 33.18

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.21 54.71
Gross Margin - 5 Yr. Avg. -- 52.54 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -239.51 15.28
Operating Margin (TTM) -- -519.41 7.56
Operating Margin - 5 Yr. Avg. -- -256.70 10.75
Pre-Tax Margin (TTM) -- -494.96 8.34
Pre-Tax Margin - 5 Yr. Avg. -- -256.63 11.15
Net Profit Margin (TTM) -- -496.46 4.66
Net Profit Margin - 5 Yr. Avg. -- -259.85 7.45
Effective Tax Rate (TTM) -- 23.29 23.07
Effective Tax Rate - 5 Yr. Avg. -- 18.77 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,318,311 858,000,222
Net Income/Employee (TTM) -942,463 3,079,098 100,930,107
Receivable Turnover (TTM) -- 20.24 5.77
Inventory Turnover (TTM) -- 2.31 3.35
Asset Turnover (TTM) 0.00 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.95 0.09 11.00
Return on Assets - 5 Yr. Avg. -41.17 0.51 12.38
Return on Investment (TTM) -42.00 3.19 14.44
Return on Investment - 5 Yr. Avg. -45.02 3.64 16.19
Return on Equity (TTM) -42.26 4.52 16.13
Return on Equity - 5 Yr. Avg. -47.24 8.98 17.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.85 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catalyst Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 49.38%
# of Holders: 113
Total Shares Held: 42,490,364
3 Mo. Net Change: 6,019,104
# New Positions: 9
# Closed Positions: 2
# Increased Positions: 14
# Reduced Positions: 5
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.